Velos continues adding CTSA customers – 40% now use Velos products
Fremont, California – June 30, 2015
Velos, Inc., the pioneering software company for clinical research and specialty medicine, continues to grow and add customers who receive Clinical and Translational Science Awards (“CTSAs”). More than 40% of the 62 CTSAs awarded by the National Institutes of Health currently use Velos software for clinical research information management. This is among the largest such market shares in its product class.
“Our presence in the CTSA community keeps growing as a result of our continued intense focus on the particular challenges and needs of this very important group of clinical researchers,” says John S. McIlwain, President of Velos.
As clinical studies continue to increase in complexity, it is more challenging than ever to ensure that efficiency and compliance are being addressed and that patients are being treated in the most ethical manner possible. Velos helps research organizations address these issues through an integrated platform that enables management of the entire clinical research portfolio across multiple departments and sites, while also establishing a powerful foundation designed with industry standards, scalability and interoperability in mind. The return on investment is vast and varied, including faster study setup and turnaround time, improved accrual, increased regulatory compliance, more accurate and comprehensive research billing, reduced staff workloads, and higher data quality. Velos’ solutions provide the CTSA community with a platform that creates an efficient and connected ecosystem and promotes administrative and scientific excellence while ensuring a strong, scalable and adaptable solution for their evolving needs.
Velos expects continued growth in the CTSA community through its flagship Velos eResearch product as well as Velos eResearch sister products for clinical research and translational medicine. What’s more, over the last several years the company has made major R&D investments to further extend the value and utility of its core clinical research product line. These innovations are scheduled to hit the market later in 2015 and beyond.
Velos is the trusted clinical trial management resource for investigators, sponsors and academic leaders throughout the world. Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. Velos integrates the clinical, administrative and financial information needs of research management, with an emphasis on flexibility and workflow and empowering clinical innovation. Founded in 1996, Velos, Inc. is privately held with headquarters in Fremont, California.